HIM
INVA icon

Hillsdale Investment Management’s Innoviva INVA Stock Holding History

Hillsdale Investment Management’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-315,600
Closed -$4.81M – 635
2024
Q1 		$4.81M Buy
315,600
+24,900
+9% +$391K 0.38% 82
2023
Q4 		$4.66M Buy
+290,700
New +$4.06M 0.38% 73
2021
Q2 		– Sell
-171,300
Closed -$2.05M – 612
2021
Q1 		$2.05M Hold
171,300
– – 0.17% 156
2020
Q4 		$2.12M Sell
171,300
-1,100
-0.6% -$11.9K 0.2% 144
2020
Q3 		$1.8M Hold
172,400
– – 0.18% 153
2020
Q2 		$2.41M Buy
+172,400
New +$2.35M 0.22% 140

Other funds holding INVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Hillsdale Investment Management's INVA Position: Q2 2024 in Review

Hillsdale Investment Management sold out of Innoviva (INVA) in Q2 2024, closing a stake of 315,600 shares — an estimated $4.81M sold.

Hillsdale Investment Management first reported a position in INVA in Q2 2020 and held it in 6 quarters. The position peaked at $4.81M in Q1 2024. 213 funds tracked by Wall St. Rank hold INVA as of Q2 2024.

  • Hillsdale Investment Management reported no remaining Innoviva position as of Q2 2024 after selling out during the quarter.
  • Hillsdale Investment Management sold 315,600 Innoviva shares in Q2 2024, an estimated $4.81M.
  • Hillsdale Investment Management first reported a position in Innoviva in Q2 2020 and held it in 6 quarters.
  • Hillsdale Investment Management's Innoviva position peaked at $4.81M in Q1 2024.
  • 213 funds tracked by Wall St. Rank held Innoviva as of Q2 2024.

Based on Hillsdale Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.